BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23049623)

  • 21. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
    Wang Q; Sun Z; Yang HS
    Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.
    Li JZ; Gao W; Ho WK; Lei WB; Wei WI; Chan JY; Wong TS
    Chin J Cancer; 2016 Nov; 35(1):95. PubMed ID: 27852288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer].
    Ma G; Guo KJ; Zhang H; Ozaki I; Matsuhashi S; Zheng XY; Dong M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):597-600. PubMed ID: 16274040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.
    Lo PK; Lee JS; Chen H; Reisman D; Berger FG; Sukumar S
    Exp Mol Pathol; 2013 Feb; 94(1):262-9. PubMed ID: 23103611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
    Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
    Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed cell death 4 mechanism of action: The model to be updated?
    Vikhreva PN; Kalinichenko SV; Korobko IV
    Cell Cycle; 2017 Oct; 16(19):1761-1764. PubMed ID: 28853972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
    Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
    Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
    Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
    Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer.
    Wei N; Liu SS; Chan KK; Ngan HY
    PLoS One; 2012; 7(1):e30311. PubMed ID: 22272332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PDCD4 Deficiency Aggravated Colitis and Colitis-associated Colorectal Cancer Via Promoting IL-6/STAT3 Pathway in Mice.
    Wang L; Zhao M; Guo C; Wang G; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen YH; Zhang L
    Inflamm Bowel Dis; 2016 May; 22(5):1107-18. PubMed ID: 26891257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant Expression Of PDCD4/eIF4A1 Signal Predicts Postoperative Recurrence For Early-Stage Oral Squamous Cell Carcinoma.
    Zhao M; Ding L; Yang Y; Chen S; Zhu N; Fu Y; Ni Y; Wang Z
    Cancer Manag Res; 2019; 11():9553-9562. PubMed ID: 31807078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed cell death 4 overexpression enhances sensitivity to cisplatin via the JNK/c-Jun signaling pathway in bladder cancer.
    Liu J; Zhai R; Zhao J; Kong F; Wang J; Jiang W; Xin Q; Xue X; Luan Y
    Int J Oncol; 2018 May; 52(5):1633-1642. PubMed ID: 29512740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cell migration and invasion and promotion of cell apoptosis by overexpression of programmed cell death 4 (PDCD4) in cervical cancer Siha cells.
    Zeng T; Zhang Q; Yu X; Gao X; Qiu Y
    Int J Clin Exp Pathol; 2018; 11(9):4676-4683. PubMed ID: 31949868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
    Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of decreased programmed cell death 4 expression in patients with giant cell tumors of the bone.
    Gao F; Zhang W; Ding L; Zhao M; Ma Z; Huang S
    Oncol Lett; 2018 Sep; 16(3):3805-3811. PubMed ID: 30127992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemia.
    Zhang X; Liu R; Huang B; Zhang X; Yu W; Bao C; Li J; Sun C
    Oncol Lett; 2016 Oct; 12(4):2976-2981. PubMed ID: 27698886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of programmed cell death 4 expression in malignant progression of human nasal inverted papillomas.
    Wang Y; Ding L; Zhang X; Zhao M; Qu Z; Huang S; Zhang Y; Li Y; Gao F
    Med Oncol; 2012 Dec; 29(4):2505-11. PubMed ID: 22359108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of PDCD4 by miR-21 suppresses tumor transformation and proliferation in a nude mouse renal cancer model.
    Yuan H; Xin S; Huang Y; Bao Y; Jiang H; Zhou L; Ren X; Li L; Wang Q; Zhang J
    Oncol Lett; 2017 Sep; 14(3):3371-3378. PubMed ID: 28927090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells.
    Tran TT; Rane CK; Zito CR; Weiss SA; Jessel S; Lucca L; Lu BY; Oria VO; Adeniran A; Chiang VL; Omay SB; Hafler DA; Kluger HM; Jilaveanu LB
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.
    Wang Q; Zhu J; Wang YW; Dai Y; Wang YL; Wang C; Liu J; Baker A; Colburn NH; Yang HS
    Oncogene; 2017 Nov; 36(45):6225-6234. PubMed ID: 28692058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.